santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

HDAC and Sirtuin Inhibitors

  • 4-(dimethylamino)-N-[6-(hydroxyamino)-6-oxohexyl]-benzamide
    A selective and cost-effective histone deacetylase (HDAC1) inhibitor.
    Katalog #CAS NummerSummenformelMenge
    sc-223859n.n.C15H23N3O31 mg/5 mg
  • APHA Compound 8
    An HDAC (histone deacetylase) inhibitor.
    Katalog #CAS NummerSummenformelMenge
    sc-210828676599-90-9C16H16N2O31 mg
  • ATRA-BA Hybrid
    The differentiation-inducer all-trans-Retinoic Acid and the histone deacetylase inhibitor (HDI) Butyric Acid are incorporated chemically via a benzyl ester linkage into a single more permeant mutual prodrug (MP) to help their cellular uptake and to better synergize their cancer killing efficiency.
    Katalog #CAS NummerSummenformelMenge
    sc-221275n.n.C31H40O425 mg
  • B2
    Cell permeable inhibitor of sirtuin 2 (SIRT2). Promotes inclusion formation in cellular models of both Huntington’s disease and Parkinson’s disease.
    Katalog #CAS NummerSummenformelMenge
    sc-202486115687-05-3C20H17CIN4O31 mg/5 mg
  • BIX01294 hydrochloride hydrate
    The methylation of lysine residues on histones plays a central role in determining euchromatin structure and gene expression. The histone methyltransferase (HMTase) G9a can mono- or dimethylate lysine 9 on histone 3 (H3), contributing to early embryogenesis, genomic imprinting, and lymphocyte development. BIX01294 (hydrochloride hydrate) is a selective inhibitor of G9a HMTase (IC50 = 1.7 μM). It less effectively inhibits the HMTase G9a-like protein (GLP; IC50 = 38 μM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-293525935693-62-2C28H38N6O2 ·3HCl ·xH2O1 mg/5 mg
  • BML-210
    Shown to inhibit HDAC activity in HeLa nuclear extracts, and to exert growth inhibitory, differentiation stimulating and proapoptotic effects in several human leukemia cell lines.
    Katalog #CAS NummerSummenformelMenge
    sc-221369537034-17-6C20H25N3O21 mg/5 mg
  • BML-266
    A structurally novel SIRT2 inhibitor (IC50=56.7µM).
    Katalog #CAS NummerSummenformelMenge
    sc-22137196969-83-4C30H26N2O410 mg/50 mg
  • CAY10603
    A potent and selective HDAC6 inhibitor that has been shown to be more active at inhibiting cell growth than other broad spectrum HDAC inhibitors like SAHA (sc-220139).
    Katalog #CAS NummerSummenformelMenge
    sc-2238771045792-66-2C22H30N4O6500 µg/1 mg
  • CBHA
    CBHA is a potent HDAC inhibitor and induces apoptosis in nine different neuroblastoma cell lines in culture. CBHA also completely suppresses neuroblastoma tumor growth in SCID mice at 200 mg/kg. Addition of retinoic acid increases efficacy of CBHA for suppressing tumor growth in mice.
    Katalog #CAS NummerSummenformelMenge
    sc-205240174664-65-4C10H10N2O45 mg/25 mg
  • CI 994
    HDAC inhibitor that mediates arrest of the G1 phase of the cell cycle. In in vitro and in vivo studies, will inhibit proliferation as well as induce apoptosis.
    Katalog #CAS NummerSummenformelMenge
    sc-205245112522-64-2C15H15N3O210 mg/50 mg
  • Depudecin
    Depudecin is a fungal metabolite that potently inhibits HDAC activity, , in vivo and in vitro, and has the ability to revert the morphology of transformed NIH 3T3 fibroblasts.
    Katalog #CAS NummerSummenformelMenge
    sc-200651139508-73-9C11H16O4100 µg
  • EX 527
    A selective inhibitor of SIRT1 deacetylation activity. Used as a tool for probing the functions and effects of SIRT1 deacetylation in cellular regulation.
    Katalog #CAS NummerSummenformelMenge
    sc-20304449843-98-3C13H13ClN2O5 mg
  • HC Toxin
    HC Toxin is a potent, cell-permeable histone deacetylase inhibitor with displayable antiprotozoal, antineoplastic and antitumor activity.
    Katalog #CAS NummerSummenformelMenge
    sc-20088483209-65-8C21H32N4O61 mg
  • Histone (calf thymus)
    Natural mixture of the histones H1, H2A, H2B, H3 and H4.
    Katalog #CAS NummerSummenformelMenge
    sc-22172737244-51-2n.n.10 mg
  • Histone Deacetylase (rat)
    Liquid. In 1.4mM NaH2PO4, containing 18.6mM Na2HPO4, pH 7.9, 0.25mM EDTA, ~700mM sodium chloride, 10% (v/v) glycerol and 10mM 2-mercaptoethanol.
    Katalog #CAS NummerSummenformelMenge
    sc-221728n.n.n.n.2 ml
  • Histone H1 (calf thymus)
    A mixture of Histone H1 subtypes, which are components of chromatin in eukaryotic cells. It functions as a stabilizing agent between nucleosomes.
    Katalog #CAS NummerSummenformelMenge
    sc-221729n.n.n.n.1 mg
  • HNHA
    A cell-permeable inhibitor of histone deacetylase (HDAC) activity; induces histone hyperacetylation and p21 transcription with concomitant inhibition of cell cycle progression in human fibrosarcoma HT1080 cells.
    Katalog #CAS NummerSummenformelMenge
    sc-205343926908-04-5C17H21NO2S5 mg/10 mg
  • ITSA1
    ITSA1 (N-(1H-Benzotriazol-1-yl)-2,4-dichlorobenzamide) is a specific and potent TSA suppressor.
    Katalog #CAS NummerSummenformelMenge
    sc-200894200626-61-5C13H7Cl2N3O25 mg/100 mg
  • M 344
    Potent inhibitor of histone deacetylase (HDAC) (IC50≤1µM).
    Katalog #CAS NummerSummenformelMenge
    sc-203124251456-60-7C16H25N3O31 mg/5 mg
  • MS-275
    A histone deacetylase (HDAC) inhibitor shown to preferentially block HDAC1 over HDAC3, with negligible effects on HDAC8. This compound has also been shown to induce cyclin-dependent kinase inhibitor 1A
    Katalog #CAS NummerSummenformelMenge
    sc-279455209783-80-2C21H20N4O31 mg/5 mg
  • N-(2-Aminophenyl)-N'-phenylheptanediamide
    Histone deacetylase inhibitor IV. A cell-permeable pimeloylanilide compound that acts as a FXN (frataxin gene) specific HDAC inhibitor. Reverses the silencing of FXN transcription in FRDA (Friedreich’s ataxia) cells due to hypoacetylation of histone.
    Katalog #CAS NummerSummenformelMenge
    sc-207902537034-15-4C19H23N3O210 mg
  • NSC 3852
    Histone deacetylase inhibitor. In MCF-7 human breast cancer cells, causes cell differentiation in vitro. In vivo, displays antitumor activity.
    Katalog #CAS NummerSummenformelMenge
    sc-2057733565-26-2C9H6N2O210 mg/50 mg
  • 4-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-N-hydroxybutanamide
    Katalog #CAS NummerSummenformelMenge
    sc-222083n.n.C16H14N2O41 mg/5 mg
  • Nullscript
    Katalog #CAS NummerSummenformelMenge
    sc-222084300816-11-9C16H14N2O41 mg/5 mg
  • Oxamflatin
    Potent inhibitor of mammalian HDAC. Acts as a ligand for the enzyme active site metal ion. Elevates the expression of extracellular matrix proteins fibronectin and gelsolin. Induces apoptosis in P-glyoprotein (Pgp) positive and Pgp negative multidrug resistant cells. Upregulates plasminogen activator inhibitor type 2 (PAI-2) expression with concomitant inhibition of urokinase (u-PA) gene and protein expression in HT-1080 and U-937 cells.
    Katalog #CAS NummerSummenformelMenge
    sc-205960151720-43-3C17H14N2O4S1 mg/5 mg
  • Panobinostat
    A histone deactylase inhibitor (HDAC) of research interest for in vitro studies of multiple myeloma.
    Katalog #CAS NummerSummenformelMenge
    sc-208148404950-80-7C21H23N3O22.5 mg
  • PTACH
    A HDAC inhibitor that is more potent than the majority of HDAC inhibitors except for SAHA (gold standard).
    Katalog #CAS NummerSummenformelMenge
    sc-253326848354-66-5C20H26N2O2S22 mg
  • S-Adenosylhomocysteine-d4
    S-Adenosylhomocysteine-d4 (SAH-d4) contains four deuterium atoms at the 3, 3’, 4, and 4’ positions. It is intended for use as an internal standard for the quantification of SAH by GC- or LC-mass spectrometry (MS). S-Adenosyl-L-homocysteine (SAH) is an amino acid derivative and an intermediate, by-product, or modulator of several metabolic pathways, including the activated methyl cycle and cysteine biosynthesis. It is also a product of S-adenosyl-methionine (SAM)-dependent methylation of biological molecules, including DNA, RNA, and histones and other proteins. SAH is a risk factor for many diseases, including cancer and neurodegenerative diseases. In addition, inhibitors that block its hydrolysis are being developed as anti-viral, anti-parasitic, anti-arthritic and immunosuppressive agents.
    Katalog #CAS NummerSummenformelMenge
    sc-296290n.n.C14H16D4N6O5S500 µg/1 mg
  • (S)-HDAC-42
    The dysregulation of histone acetylation contributes to the pathogenesis of some cancers. Histone deacetylases (HDACs), which participate in regulating the acetylation status of nucleosomal histones, are increasingly recognized as promising targets for cancer therapy. (S)-HDAC-42 is a potent inhibitor of HDACs (IC50 = 16 nM in vitro). It decreases the viability of prostate cancer cell lines (IC50 = 0.0 μM), increasing the expression of p21 and the acetylation of histone H3 while decreasing the phosphorylation of Akt and the expression of Bcl-XL. (S)-HDAC-42 also strongly suppresses the growth of PC-3 tumor xenografts, reducing levels of phospho-Akt and Bcl-XL protein in tumors.
    Katalog #CAS NummerSummenformelMenge
    sc-296364935881-37-1C18H20N2O31 mg/5 mg
  • Salermide
    A reverse amide with strong inhibitory effects on Sirtuin 1 and Sirtuin 2. Found to cause acetylation of p53 and cause massive induction of cell apoptosis.
    Katalog #CAS NummerSummenformelMenge
    sc-2242761105698-15-4C26H22N2O25 mg/10 mg
  • Scriptaid
    A histone deacetylase inhibitor (HDAC). Reported to inhibit all three class I HDACs, elevate the expression of the estrogen receptor α, reactivate the latent HIV-1 promoter, and illicit glioma cell apoptosis.
    Katalog #CAS NummerSummenformelMenge
    sc-202807287383-59-9C18H18N2O41 mg/5 mg
  • SIRT1 Inhibitor IV, (S)-35
    SIRT 1 inhibitor IV, (S)-35 is a sirtuin protein that has high potency (IC50= 38 nM). It is an entomerically pure compound that can permeate the cell and is metabolically stable.
    Katalog #CAS NummerSummenformelMenge
    sc-204279848193-72-6C14H15ClN2O500 µg
  • SIRT1/2 Inhibitor IV, Cambinol
    A cell-permeable β-naphthol compound that inhibits the NAD-dependent deacetylase activity of hSIRT1 and hSIRT2 (IC50 = 56 µM and 59 µM, respectively) in a substrate-, but not NAD-, competitive manner.
    Katalog #CAS NummerSummenformelMenge
    sc-20428014513-15-6C21H16N2O2S5 mg
  • SIRT2 Inhibitor, AGK2
    A reversible inhibitor of SIRT2. Shown to protect against α-synuclein-induced toxcity and dopaminergic cell death in Parkinson’s disease models.
    Katalog #CAS NummerSummenformelMenge
    sc-202813304896-28-4C23H13Cl2N3O25 mg
  • SIRT2 Inhibitor, Inactive Control, AGK7
    Cell-permeable structural isomer of SIRT2 Inhibitor, AGK2 (sc-202813) that selectively inhibits sirtuin 3 over sirtuins 1 and 2 (IC50 = >5 µM, >50 µM and >50 µM for SIRT3, SIRT1 and SIRT2, respectively). Poorly affects both α-synuclein-mediated toxicity and α-Syn aggregation in α-Syn-H4 cells.
    Katalog #CAS NummerSummenformelMenge
    sc-204281304896-21-7C23H13Cl2N3O25 mg
  • Sirtinol
    A cell permeable specific inhibitor of sirtuin NAD-dependant deacetylases. The compound also displays senescence in cancer cells and acts as a hormone in plants.
    Katalog #CAS NummerSummenformelMenge
    sc-205976410536-97-9C26H22N2O21 mg/5 mg
  • Sodium Phenylbutyrate
    A low molecular weight fatty acid shown to cause cellular differentiation, growth arrest, and apoptosis. Also reported to act as a chemical chaperone.
    Katalog #CAS NummerSummenformelMenge
    sc-2006521716-12-7C10H11O2··Na1 g
  • Splitomicin
    A cell-permeable lactone that acts as a selective inhibitor of NAD+ dependent histone deacetylase activity of Sir2 protein. It creates a conditional phenocopy of a sir2 deletion mutant in S. cerevisiae and sensitizes mammalian cells to a variety of DNA-damaging agents by abrogating Sir2p activity on p53. Acts by either altering or blocking access to the acetylated histone binding pocket.
    Katalog #CAS NummerSummenformelMenge
    sc-3587015690-03-9C13H10O25 mg
  • Suberoyl bis-hydroxamic Acid
    A histone deacetylase inhibitor that has been shown to induce apoptosis in proliferating cells via induction of P21, P53, PUMA, and Bax gene expression.
    Katalog #CAS NummerSummenformelMenge
    sc-20088738937-66-5C8H16N2O4100 mg/500 mg
  • Suberoylanilide Hydroxamic Acid
    A potent HDAC inhibitor that results in cell cycle arrest, downregulation of survivin and Bcl-xL, and apoptosis.
    Katalog #CAS NummerSummenformelMenge
    sc-220139149647-78-9C14H20N2O3100 mg
  • Suberoylanilide-d5 Hydroxamic Acid
    A potent, selective, cell permeable histone deacetylase inhibitor (HDAC). Displays anti-angiogenic activity by interfering with VEGF signaling in human umbilical vein endothelial cells (HUVECs). Induces differentiation in uman breast cancer cells.
    Katalog #CAS NummerSummenformelMenge
    sc-220140n.n.C14H15D5N2O31 mg
  • Suramin Sodium
    Uncouples G proteins from receptors presumably by blocking their interaction with intracellular receptor domains. Inhibits cell surface binding of various growth factors including PDGF, EGF and TGF-β.
    Katalog #CAS NummerSummenformelMenge
    sc-200833129-46-4C51H34N6O23S6 ·Na650 mg/250 mg
  • Tenovin-1
    A compound that belongs to the class of Tenovins, and inhibit the protein activities of SirT1 and SirT2. Shown to activate and elevate acetylated p53 levels, induce apoptosis in vitro, and acetylate histone H4.
    Katalog #CAS NummerSummenformelMenge
    sc-222342380315-80-0C20H23N3O2S10 mg
  • Tenovin-6
    A water soluble analog of Tenovin-1, that acts as a potent SirT1 and SirT2 inhibitor, and p53 activator. Shown to increase p53 levels more than Tenovin-1.
    Katalog #CAS NummerSummenformelMenge
    sc-2242961011557-82-6C25H34N4O2S1 mg/5 mg
  • Trapoxin A
    A cyclotetrapeptide and a histone deacetylase (HDAC) inhibitor. Trapoxin increases the level of chromatin acetylation associated with histone H3 at low nanomolar concentrations.1 Unlike the reversible HDAC inhibition induced by TCA, Trapoxin irreversibly inhibits HDAC activity in crude cell lysates and induces the accumulation of hyperacetylated core histones in a number of mammalian cell lines and tissues.2, Histone acetylation and methylation have been studied extensively for their anti-tumor activities in carcinogenesis and Trapoxin has been suggested as a potential anticancer agent for pre-clinical trials.3
    Katalog #CAS NummerSummenformelMenge
    sc-253730133155-89-2C34H42N4O61 mg
  • Trichostatin A
    Inhibits histone deacetylation; blocks cell cycle at G1; induces reversion of Ras transformed cells to normal morphology; inhibits IL-2 expression in Jurkat cells.
    Katalog #CAS NummerSummenformelMenge
    sc-351158880-19-6C17H22N2O31 mg/5 mg
  • Valproic Acid, Sodium Salt
    A branched chain, fatty acid with multiple reported effects; enhances GABAergic neurotransmission, potent inhibitor of histone deacetylases (HDACs) which leads to hyperacetylation of histones in cultured cells.
    Katalog #CAS NummerSummenformelMenge
    sc-2023781069-66-5C8H15NaO25 g